Autosomal Dominant Craniometaphyseal Dysplasia

dominant form due to mutation in human homolog of mouse ANKH gene

Also Known As:

Craniometaphyseal Dysplasia, Autosomal Dominant; Craniometaphyseal Dysplasia, Jackson Type; Craniometaphyseal dysplasia Jackson type; Craniometaphyseal dysplasia autosomal dominant; Craniometaphyseal dysplasia dominant type

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Experts

1.	Baur, S T: 1 article (06/2001)
2.	Beighton, P: 1 article (06/2001)
3.	Gardner, J: 1 article (06/2001)
4.	Gorlin, R J: 1 article (06/2001)
5.	Grange, D K: 1 article (06/2001)
6.	Hamersma, H: 1 article (06/2001)
7.	Lidral, A C: 1 article (06/2001)
8.	Mulliken, J B: 1 article (06/2001)
9.	Olsen, B R: 1 article (06/2001)
10.	Park, L: 1 article (06/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Autosomal Dominant Craniometaphyseal Dysplasia:

1.	Somatotropin Receptors (Growth Hormone Receptor)IBA 10/01/1997 - "The gene for autosomal dominant craniometaphyseal dysplasia maps to chromosome 5p and is distinct from the growth hormone-receptor gene."
2.	Proteins (Proteins, Gene)FDA Link 06/01/2001 - "Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK."